z-logo
open-access-imgOpen Access
Adalimumab Biosimilar Efficacy and Safety in a 5-Year-Old Patient with Severe Plaque Psoriasis During SARS-CoV-2 Pandemic Outbreak
Author(s) -
Lucia Gallo,
Gianmarco Capasso,
Francesca Fiori Nastro,
Gabriella Fabbrocini,
Matteo Megna
Publication year - 2022
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2022.7575
Subject(s) - medicine , adalimumab , biosimilar , psoriasis , dermatology , plaque psoriasis , outbreak , infliximab , population , pandemic , etanercept , tumor necrosis factor alpha , disease , covid-19 , pathology , infectious disease (medical specialty) , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom